Literature DB >> 30324577

The influence of chronic kidney disease on the duration of hospitalisation and transfusion rate after elective hip and knee arthroplasty.

C Kaiser1, F P Tillmann2, J Löchter1, S Landgraeber1, M Jäger3.   

Abstract

PURPOSE: Elective hip or knee replacement is an optimal, standardised orthopaedic surgical procedure. The influence of chronic kidney disease, defined as an estimated glomerular filtration rate (eGFR) of 15-45 ml/min/1.73 m2 body surface area (BSA) (KDIGO stage G3a-G4), on the duration of hospitalisation, perioperative decrease in haemoglobin (Hb) levels, and transfusion rates after orthopaedic procedures has not been fully clarified. Our study, therefore, aimed to evaluate the impact of chronic kidney disease on the previously mentioned variables.
METHODS: We conducted a retrospective multicentre analysis involving two orthopaedic centres. Patients who underwent elective total hip and knee replacement between 2010 and 2015 were included. We used descriptive methods and multivariate linear and binary regression analyses for our statistical evaluations.
RESULTS: We evaluated 3301 datasets (1120 men [33.9%], 2181 women [66.1%], 2043 [61.9%], and 1258 [38.1%]) elective total hip and knee replacements, respectively. The following variables were identified as risk factors for a prolonged hospital stay: patient age, admission Hb and potassium levels, perioperative Hb level decrease, year of surgery, blood transfusion, and a preoperative eGFR of 15-45 ml/min/m2 BSA. Patients with an eGFR of > 45 ml/min/m2 BSA were discharged within 11.7 ± 3.0 days, while patients with an eGFR of 15-45 ml/min/1.73 m2 BSA remained inpatient for 13.5 ± 5.0 days (p < 0.001). Identified risk factors for postoperative blood transfusions included age, initial Hb level, perioperative Hb decrease, prosthetic hip replacement, and the presence of allergic diathesis. Blood transfusions were performed in 7.5% of patients with an eGFR of > 45 ml/min/m2 BSA compared to 24.1% of patients with an eGFR of 15-45 ml/min/1.73 m2 BSA (p < 0.001). An eGFR level of 15-45 ml/min/m2 BSA was identified as a risk factor for a postoperative decrease in Hb levels.
CONCLUSION: Chronic kidney disease, defined as an eGFR level of 15-45 ml/min/1.73 m2 BSA, was a risk factor for a prolonged hospital stay after elective hip and knee arthroplasty. Further studies are necessary to better define the effect of reduced kidney function on relevant clinical and socioeconomic outcome parameters.

Entities:  

Keywords:  Blood transfusion; CKD; Joint replacement; Prolonged inpatient stay

Mesh:

Year:  2018        PMID: 30324577     DOI: 10.1007/s11255-018-2008-5

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  23 in total

Review 1.  The operation of the century: total hip replacement.

Authors:  Ian D Learmonth; Claire Young; Cecil Rorabeck
Journal:  Lancet       Date:  2007-10-27       Impact factor: 79.321

2.  Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey.

Authors:  Chi-Yuan Hsu; Charles E McCulloch; Gary C Curhan
Journal:  J Am Soc Nephrol       Date:  2002-02       Impact factor: 10.121

Review 3.  Coagulation disorders in uremia.

Authors:  Daniela Molino; Domenico De Lucia; Natale Gaspare De Santo
Journal:  Semin Nephrol       Date:  2006-01       Impact factor: 5.299

4.  Hospitalizations for total hip arthroplasty after renal transplantation in the United States.

Authors:  Jay R Bucci; Robert J Oglesby; Lawrence Y Agodoa; Kevin C Abbott
Journal:  Am J Transplant       Date:  2002-11       Impact factor: 8.086

5.  Chronic kidney disease and postoperative morbidity after elective orthopedic surgery.

Authors:  Gareth L Ackland; Noeleen Moran; Steven Cone; Michael P W Grocott; Michael G Mythen
Journal:  Anesth Analg       Date:  2010-08-31       Impact factor: 5.108

6.  Total hip arthroplasty in chronic dialysis patients in the United States.

Authors:  Kevin C Abbott; Jay R Bucci; Lawrence Y Agodoa
Journal:  J Nephrol       Date:  2003 Jan-Feb       Impact factor: 3.902

7.  The effect of chronic kidney disease on total hip arthroplasty.

Authors:  Alexander Miric; Maria C S Inacio; Robert S Namba
Journal:  J Arthroplasty       Date:  2014-01-08       Impact factor: 4.757

8.  The prescreening history and physical in elective total joint arthroplasty.

Authors:  John B Meding; Melissa Klay; Angela Healy; Merrill A Ritter; E Michael Keating; Michael E Berend
Journal:  J Arthroplasty       Date:  2007-07-26       Impact factor: 4.757

9.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

10.  Association between chronic kidney disease and blood transfusions for knee and hip arthroplasty surgery.

Authors:  Ian D Augustin; Tze Yeng Yeoh; Juraj Sprung; Daniel J Berry; Darrell R Schroeder; Toby N Weingarten
Journal:  J Arthroplasty       Date:  2013-03-19       Impact factor: 4.757

View more
  3 in total

1.  Preoperative Intravenous Iron and Erythropoietin to Treat Severe Anemia in Patient With Stage 4 Kidney Disease Before Oncologic Surgery: A Case Report.

Authors:  Betty M Luan-Erfe; Meltem Yilmaz; BobbieJean Sweitzer
Journal:  A A Pract       Date:  2020-06

2.  Development and validation of a nomogram to predict perioperative blood transfusion in patients undergoing total knee arthroplasty.

Authors:  Chuan Hu; Yuan-He Wang; Rui Shen; Chuan Liu; Kang Sun; Lin Ye; Jian-Jun Ye; Xu Yang; Shao-Qi Tian; Teng-Bo Yu
Journal:  BMC Musculoskelet Disord       Date:  2020-05-20       Impact factor: 2.362

Review 3.  Effect of chronic kidney disease on total knee arthroplasty outcomes: a meta-analysis of matched control studies.

Authors:  Chongjie Cheng; Yan Yan; Qidong Zhang; Wanshou Guo
Journal:  Arthroplasty       Date:  2021-07-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.